{"id":"W4380854067","doi":"10.1182/blood.2022019386","title":"Five-year follow-up of KEYNOTE-087: pembrolizumab monotherapy for relapsed/refractory classical Hodgkin lymphoma","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":105,"is_retracted":false,"has_abstract":true,"ca_institutions":"Jewish General Hospital","funders":"Genentech","keywords":"Medicine; Pembrolizumab; Internal medicine; Discontinuation; Cohort; Adverse effect; Brentuximab vedotin; Surgery; Salvage therapy; Chemotherapy; Lymphoma; Cancer; Immunotherapy; Hodgkin lymphoma","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003588806,0.0004638351,0.001169836,0.0009806004,0.0006593648,0.0007627851,0.0004279028,0.0008909807,0.001824254],"category_scores_gemma":[0.003632375,0.0002010049,0.0008998768,0.0006902911,0.0002694987,0.0008659199,0.0007109955,0.001247575,0.0006532895],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007890802,"about_ca_system_score_gemma":0.0004224668,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001735264,"about_ca_topic_score_gemma":0.001870083,"domain_scores_codex":[0.9988438,0.0002875442,0.0001620383,0.0002031502,0.0002425204,0.0002608925],"domain_scores_gemma":[0.9963328,0.0006672734,0.001177663,0.0003778705,0.00079702,0.000647452],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.06629098,0.004016407,0.7928123,0.000524433,0.002479935,0.001687282,0.0007707983,0.002176023,0.0103822,0.0002329489,0.005360804,0.1132659],"study_design_scores_gemma":[0.000938406,0.02088912,0.9688682,0.00005914827,0.001299901,0.0007059711,0.0001417366,0.000877241,0.001831399,0.0001131991,0.004231894,0.00004388322],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9900982,0.00221476,0.0006062211,0.0001206859,0.00003058464,0.0002165429,0.003835323,0.00006583698,0.002811785],"genre_scores_gemma":[0.9923368,0.0002850671,0.0001603802,0.0001640546,0.00003003877,0.0000957087,0.005981743,0.000008537862,0.0009375997],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003588806,"threshold_uncertainty_score":0.01897967,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02062562091102287,"score_gpt":0.2741899358055085,"score_spread":0.2535643148944856,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}